JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $167,238 | +799.8% | 90,399 | +439.9% | 0.00% | – |
| Q4 2022 | $18,586 | -99.5% | 16,744 | -98.8% | 0.00% | -100.0% |
| Q3 2022 | $3,407,000 | -33.7% | 1,455,862 | -14.1% | 0.00% | 0.0% |
| Q2 2022 | $5,136,000 | -56.0% | 1,694,867 | -1.3% | 0.00% | -50.0% |
| Q1 2022 | $11,664,000 | -19.2% | 1,717,754 | -0.7% | 0.00% | -33.3% |
| Q4 2021 | $14,438,000 | +11.8% | 1,729,036 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $12,913,000 | -10.9% | 1,737,951 | -18.5% | 0.00% | 0.0% |
| Q2 2021 | $14,492,000 | -36.8% | 2,131,201 | -4.6% | 0.00% | -50.0% |
| Q1 2021 | $22,942,000 | +70.8% | 2,233,847 | +16.4% | 0.01% | +100.0% |
| Q4 2020 | $13,436,000 | +1102.9% | 1,919,549 | +1302.9% | 0.00% | – |
| Q3 2020 | $1,117,000 | -66.4% | 136,825 | -71.6% | 0.00% | -100.0% |
| Q2 2020 | $3,326,000 | +784.6% | 481,902 | +507.3% | 0.00% | – |
| Q1 2020 | $376,000 | -35.7% | 79,346 | +18.4% | 0.00% | – |
| Q4 2019 | $585,000 | +1525.0% | 67,016 | +528.1% | 0.00% | – |
| Q3 2019 | $36,000 | -80.0% | 10,669 | -70.7% | 0.00% | – |
| Q2 2019 | $180,000 | -63.1% | 36,404 | -53.8% | 0.00% | – |
| Q1 2019 | $488,000 | +67.1% | 78,713 | -9.1% | 0.00% | – |
| Q4 2018 | $292,000 | -81.3% | 86,558 | -63.9% | 0.00% | -100.0% |
| Q3 2018 | $1,560,000 | -64.4% | 239,930 | -58.0% | 0.00% | -50.0% |
| Q2 2018 | $4,380,000 | -33.0% | 571,771 | +95.4% | 0.00% | -50.0% |
| Q1 2018 | $6,539,000 | +3169.5% | 292,585 | +1953.9% | 0.00% | – |
| Q2 2017 | $200,000 | – | 14,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |